Reproductive endocrinology: live birth prediction in polycystic ovary syndrome.
Anovulatory infertility is common in polycystic ovary syndrome (PCOS). Clinicians who provide first-line treatment have to decide how best to induce ovulation with the desired outcome of live birth, a decision often complicated by the phenotypic heterogeneity of PCOS. could a new livebirth prediction model of different ovulation induction methods developed from basic clinical parameters help select infertility treatments?
Nader
Shahla
S
Department of Obstetrics and Gynecology (Division of Reproductive Endocrinology and Infertility), University of Texas Medical School at Houston, 6431 Fannin Street, Suite 3.604, Houston, TX 77030, USA. shahla.nader-eftekhari@uth.tmc.edu
D000328:Adult; D002996:Clomiphene / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage; D007247:Infertility, Female / Q000209:etiology / Q000628:therapy; D050498:Live Birth; D008687:Metformin / Q000008:administration & dosage*; D009765:Obesity / Q000150:complications; D010062:Ovulation Induction; D010641:Phenotype; D011085:Polycystic Ovary Syndrome / Q000150:complications*; D011247:Pregnancy; D011248:Pregnancy Complications; D016032:Randomized Controlled Trials as Topic
D007004:Hypoglycemic Agents; D002996:Clomiphene; D008687:Metformin